# Advisor Review - Advisor 3/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-26T03:36:32.509817
**Response ID:** resp_0afe587a50f36b38006976d27a448c8194a3b1d7a2cb89aeee
**Tokens:** 7792 in / 6004 out
**Response SHA256:** 75d57c7ebf694650

---

## Fatal-error audit (pre-submission)

I checked every quantitative object and every place where timing/sample definitions interact with the DiD design (Sections 3–6; Tables 1–4).

### 1) Data–Design Alignment (CRITICAL)
- **Treatment timing vs. data coverage:** Max treatment cohort shown is **2023** (Table 4) and the outcome data run through **2023** (Sections 3.1–3.2). So **max(treatment year) ≤ max(data year)** holds.
- **Post-treatment observations exist:**  
  - 2018 cohort has post years through 2023 (event time up to +5, Table 2).  
  - 2023 cohort has at least the **treatment-year (“event time 0”)** observation in 2023 (Table 2). That is sufficient for an “on-impact” ATT, even though longer-run dynamics for that cohort are not identifiable in this sample.
- **Treatment definition consistency across the paper:** The stated definition (“year of first legal bet / availability,” with mid-year launches coded as treated in that calendar year) is used consistently in Sections 3.1–3.2 and matches the cohort table (Table 4). No internal contradiction found that would make the analysis impossible.

**No fatal data-design misalignment detected.**

---

### 2) Regression Sanity (CRITICAL)
Checked Tables 1–3 (main ATT/TWFE) and Table 2 (event study):
- **No impossible values:** No NA/NaN/Inf; no negative SE; no impossible CIs.
- **SE magnitude checks:** SEs are plausible given the outcome is *jobs* (levels). Largest SE shown is **952** (Table 2, event time +5), not obviously indicative of a broken regression (and not exceeding the “SE > 100 × |coef|” red flag).
- **Coefficient magnitude checks:** Coefficients are in the tens to hundreds of jobs; nothing absurd for state-level employment in an industry.

**No fatal regression-output pathology detected.**

---

### 3) Completeness (CRITICAL)
- **No placeholders:** I did not see “TBD/TODO/XXX/NA” placeholders in tables or text.
- **Tables report N and uncertainty:** Tables 1–3 include **N, SE, CI, p-value**; Table 2 includes **ATT, SE, CI** (and notes about clustering).
- **Methods described are actually shown:** The key estimators discussed (Callaway–Sant’Anna ATT and TWFE comparison) and the event study are reported in tables; robustness checks mentioned in text include numeric results (Section 6).

**No fatal incompleteness detected.**

---

### 4) Internal Consistency (CRITICAL)
- **Numbers match across abstract/text/tables:** Abstract and Section 5 match Table 1 (ATT = −56, SE = 336, p = 0.87; TWFE = −205, SE = 243).
- **Confidence intervals match coefficients/SEs:** E.g., −56 ± 1.96·336 ≈ [−714, 602] (Table 1) is consistent.
- **Sample definitions match cohort counts:** Table 4 cohort totals sum to 30 treated + 16 never-treated = 46 states, matching Section 3.2 / Table 1 notes. Dropped states are consistently described.

**No fatal internal inconsistency detected.**

---

ADVISOR VERDICT: PASS